期刊文献+

2009年深圳市劳务工乙型脑炎抗体水平调查分析 被引量:3

A survey of Japanese encephalitis antibody migrant workers in Shenzhen 2009
原文传递
导出
摘要 目的 了解劳务工乙型脑炎(简称乙脑)抗体水平现状,为乙脑防治决策提供科学依据.方法 采用多阶段数字表法随机抽样,抽取44家工厂1003名年龄≥18岁、〈60岁的工人进行个案调查,并采集血清标本,采用酶联免疫吸附试验检测乙脑抗体.结果 深圳市劳务工乙脑抗体阳性率为20.2%(203/1003),男性21.2%(103/485),女性19.3%(100/518),χ2=579,P〉0.05;各年龄组乙脑抗体阳性率:〈20岁组22.6%(12/53),20~岁组18.7%(120/642),30~岁组26.0%(58/223),40~59岁组15.3%(13/85),χ2=7.96,P〉0.05.有免疫史者抗体阳性率为22.1%(30/136),无免疫史者为22.1%(51/231),免疫史不详者为19.2%(122/636),χ2=501,P〉0.05.来源于广东的劳务工乙脑抗体阳性率最高,为30.5%(50/164),其次是广西29.7%(22/74);最低是陕西5.4%(2/37),χ2=49,P〈0.05.管理人员乙脑抗体阳性率最高,为29.0%(31/107);专业人员最低,为7.1%(1/14);χ2=21.78,P〈0.05.本科及以上抗体阳性率最高,为32.7%(16/49);大专最低,为10.3%(10/97);χ2=13.02,P〈0.05.结论 深圳市劳务工乙脑抗体阳性率高低与其年龄、性别、疫苗免疫史无关,与劳务工来源地区、职业岗位、文化程度有关.劳务工乙脑免疫水平较低,免疫屏障尚未形成,提示需要加强劳务工乙脑防治工作. Objective To understand the immunological status of Japanese encephalitis (JE) antibodies amongst migrant workers and to provide epidemiological basis for public health strategies on JE prevention and control in Shenzhen. Methods A multi-stage random sampling method was used, and 1003 migrant workers aged 18 to 60 from 44 factories were investigated and their serum specimens were collected. The enzyme-linked immunosorbent assay (ELISA) was used to detect JE antibodies qualitatively. Results The gross IgG seroprevalence rate for JE was 20. 2% (203/1003). Sex-specified seroprevalence was 21.2% (103/485) for male and 19. 3% (100/518) for female,respectively (χ2 = 579,P 〉0. 05). Age-specific seropositive rates were 22. 6% (12/53) for those below 20 years old, 18. 7% (120/642) for those between 20 -years old,26. 0% (58/223) for those between 30 -years old and 15. 3% (13/85)for those on or above 40 years old (χ2 =7.96,P〉0.05). Proportions for self-reported positive immunization,non-immunization and unclear immunization history were 22. 1% (30/136) ,22. 1% (51/231)and 19. 2% (122/636), respectively (χ2 = 501, P 〉 0. 05). Seroprevalence by region of origins showed that workers from Guangdong province was the highest (30. 5%, 50/164), followed by workers from Guangxi (29.7%,22/74) whilst workers from Shan(3) xi (5.4% ,2/37) had the lowest rate. Seroprevalence rate for managers (29.0% ,31/107) was higher than that of technicians (7. 1% ,1/14) (χ2 =21.78,P〈0.05).Serological positive rate of workers with university or above educational background was the highest (32. 7 %, 16/49), followed by that for individuals with college degree (10. 3 %, 10/97) (χ2 = 13.02, P 〈0. 05). Conclusion No associations are detected between JE seroprevalence and age, or sex, or self-reported immunization histories amongst migrant labor workers in Shenzhen. However, correlations between JE serological positive rate and region of origins,occupation and educational attainment are found to be significant. The gross seroprevalence of JE antibodies suggests that the level of JE antibodies amongst Shenzhen migrant workers is low and the population immunity barrier has yet to be established. It is necessary to strengthen prevention and control strategies of JE among labor workers of Shenzhen.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2010年第9期806-809,共4页 Chinese Journal of Preventive Medicine
基金 2009年深圳市科技计划项目(200902079)
关键词 暂居者和移居者 脑炎 日本 抗体生成 酶联免疫吸附测定 Transients and migrants Encephalitis,Japanese Antibody formation Enzyme-linked immunosorbent assay
  • 相关文献

参考文献6

二级参考文献42

  • 1陈品全,周本立,马文信,李昭毅,朱进,张建林,翁正一,江秀坤.SA_(14)-14-2株乙型脑炎活疫苗流行病学效果观察[J].中国生物制品学杂志,1992,5(3):135-137. 被引量:20
  • 2汤德元,郭万柱.日本脑炎病毒及其疫苗的研究[J].中国兽医学报,2005,25(2):217-221. 被引量:17
  • 3丁志芬,常振彦,张劲锋,石慧颖,刘培生,张银凤,郭喜玲,薛亚明,耿丽华.婴幼儿对地鼠肾细胞培养乙型脑炎灭活疫苗的中和抗体应答[J].中国生物制品学杂志,1994,7(1):36-38. 被引量:7
  • 4窦彦蓉.宿迁市2001年~2004年乙型脑炎流行状况分析[J].江苏预防医学,2006,17(2):26-27. 被引量:4
  • 5董学书.云南蚊类志(上卷)[M].昆明:云南科技出版社,1993.1-37 2.
  • 6俞永新 汪金凤.流行性乙型脑炎病毒SA14-14-2弱毒株某些体外特征的研究[J].病毒学报,1986,2(3):197-201.
  • 7貌盼勇 何红霞 朱关福 见:闻玉梅 主编.乙型脑炎病毒[A].见:闻玉梅,主编.现代医学微生物学[M].上海:上海医科大学出版社,1999.1193-1204.
  • 8俞永新 张延龄 张晖 主编.流行性乙型脑炎疫苗[A].张延龄,张晖,主编.免疫学[C].北京:北京科学出版社,2004.1186-1212.
  • 9Chang GJ,Kuno G,Purdy DE,et al.Recent advancement in flavivirus vaccine development.Expert Rev Vaccines,2004,3:199-220.
  • 10Monath TP,McCarthy K,Bedford P,et al.Clinical proof of principle for ChimeriVax:recombinant live,attenuated vaccines against flavivirus infections.Vaccine,2002,20 (7-8):1004-1018.

共引文献41

同被引文献47

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部